New flu vaccine for seniors enters safety testing
NCT ID NCT07421037
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial is testing the safety of a new quadrivalent influenza vaccine with an adjuvant (a booster ingredient) in adults aged 65 and older. Eighty participants will receive either the new vaccine, a standard flu vaccine, or a placebo. The study monitors side effects over 12 months to see if the vaccine is safe for this age group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Quadrivalent subunit influenza vaccine with adjuvant (MF59)
What this could lead to
If successful, this could lead to a safer, more effective flu vaccine for older adults, who are at higher risk of severe flu complications.
What could go wrong
This is an early Phase 1 trial with only 80 participants, focused on safety, not effectiveness. The vaccine may not provide better protection than existing flu shots, and side effects are still being evaluated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yunxi County Center for Disease Control and Prevention
Shiyan, Hubei, China